Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway
Authors
- Xin‐Lei Guan (ORCID: https://orcid.org/0000-0001-6512-0837)
- Maochang Liu (ORCID: https://orcid.org/0000-0002-2371-4060)
- Lili Liu (ORCID: https://orcid.org/0000-0003-2509-2362)
- Chengliang Zhang (ORCID: https://orcid.org/0000-0001-9429-4764)
- Ping Gao (ORCID: https://orcid.org/0000-0003-0101-7798)
- Xiaoyi Du (ORCID: https://orcid.org/0000-0002-3114-2613)
- Hua Dong Xu (ORCID: https://orcid.org/0000-0001-9730-7276)
Institutions
- Union Hospital (HK)
- Wuhan Puai Hospital (CN)
- Wuhan Children's Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.3389/fphar.2025.1710116
- Primary Topic
- Drug-Induced Hepatotoxicity and Protection
- Type
- article
- Field-Weighted Citation Impact
- 0.00